Objective: Racial disparities in the outcomes of patients undergoing carotid endarterectomy (CEA) have been reported. We sought to examine the contemporary relationship between race and outcomes and to report postdischarge events after CEA. Methods: The American College of Surgeons National Surgical Quality Improvement Program Participant Use Data Files were reviewed to identify all CEAs performed from 2005 to 2010 by vascular surgeons. The influence of race on outcomes was examined. Multivariate analysis was performed using variables found to be significant on bivariate analysis. The primary outcomes were stroke and mortality. Secondary outcomes were other 30-day complications, including postdischarge events. Results: CEA was performed on 29,114 white patients (95.7%) and on 1316 black patients (4.3%); the overall stroke and mortality rates were 1.65% and 0.7%, respectively. The stroke rate was 1.6% for whites and 2.5% blacks (P [ .009). The 30-day mortality rate was 0.7% for whites and 1.4% for blacks (P [ .002). There was a longer operating time (P < .001) and total length of stay (P < .001), more postoperative pneumonias (P [ .049), unplanned intubations (P < .001), ventilator dependence (P < .001), cardiac arrests (P < .001), bleeding requiring transfusions (P [ .024), and reoperations within 30 days (P [ .021) among black patients. Multivariate logistic regression modeling identified black race as an independent risk factor for 30-day mortality (odds ratio, 1.9; P [ .007). Black patients also had a greater proportion of in-hospital deaths than white patients (73.7% vs 43.1%; P [ .01). There was no between-group difference in the rate of postdischarge strokes. Thirty-six percent of all strokes occurred after discharge at a mean of 8.3 days, and 54.3% of deaths occurred after discharge at a mean of 11 days. Conclusions: Black race is an independent risk factor for 30-day mortality after CEA. A significant proportion of strokes and deaths occur after discharge in both racial groups evaluated. (J Vasc Surg 2013;57:1325-30.) 
Stroke is the fourth leading cause of death in the United States, contributing to approximately 135,000 deaths in 2008, with blacks having a higher mortality than whites. 1 Although white race has been determined to be a significant and independent risk factor for carotid stenosis, 2 black patients are less likely to undergo an imaging study of their carotids even after presenting with a transient ischemic attack (TIA) or ischemic stroke. 3 White race has been identified as an independent predictor of intervention with carotid endarterectomy (CEA) or stenting, 4 suggesting that white patients are more likely than black patients to receive treatment for carotid artery stenosis.
These observations are important, because the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomatic Carotid Atherosclerosis Trial (ACAS) both demonstrated the benefit of CEA over medical management in patients with carotid stenosis. [5] [6] [7] The ACAS findings were confirmed by the Asymptomatic Carotid Surgery Trial Group (ACST) in 2004, which demonstrated that in asymptomatic patients aged <75 years with >70% lumen reduction on ultrasound imaging, immediate CEA decreased the net 5-year stroke risk from w12% to 6% vs medical management. 8 The findings of NASCET, ACAS, and ACST would suggest the benefit of CEA, but it is unclear if these results can be extrapolated to all patient populations and address current disparities in the evaluation and treatment of carotid disease.
The purpose of this study was to examine the immediate and postdischarge outcomes of white and black patients who underwent CEA and determine if race was an independent risk factor for adverse events after CEA.
METHODS
The American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) Participant Use Data Files were used to identify all CEAs performed between 2005 and 2010. The ACS-NSQIP is a nationally validated, risk-adjusted, outcomes-based program. 11, 12 It uses a prospective, peer-controlled, multicentered database that collects data on preoperative patient comorbidities, intraoperative variables, and 30-day mortality and morbidity outcomes for patients undergoing major surgical procedures. Details regarding data acquisition, coding, sampling procedures, and inclusion criteria in the NSQIP are described elsewhere.
The analysis included all adult patients who were identified as black or white and whose principal operative procedure was designated as CEA by primary Current Procedural Terminology (CPT; American Medical Association, Chicago, Ill) code (CPT 35301 or 35390). The analysis excluded patients with CPT codes designating CEA as a secondary or concurrent procedure. For consistency, any patient whose surgeon was not identified as a vascular surgeon was also excluded.
Patient variables analyzed included age, sex, smoking history, hypertension, diabetes mellitus, chronic obstructive pulmonary disease, dialysis, congestive heart failure 30 days before surgery, angina 1 month before surgery, myocardial infarction 6 months before, any history of major prior cardiac surgery, and any history of prior percutaneous coronary intervention. Additional factors examined were the type of anesthesia used, whether patients were admitted from home or a facility, and the experience level of the resident involved in the case. We also analyzed the presence of preoperative factors specific to patients who undergo carotid interventions, such as history of TIA attack and a history of prior stroke, with and without persistent neurologic deficits.
The primary outcomes were stroke and 30-day mortality. Other outcomes measured were operating time, length of total hospitalization, length of postoperative hospitalization, myocardial infarction, peripheral nerve injury, return to the operating room #30 days, wound infection, pneumonia, unplanned intubation, pulmonary embolism, ventilator dependence >48 hours, cardiac arrest, acute renal failure, bleeding requiring transfusion, and deep venous thrombosis.
Statistical analysis was performed using IBM SPSS Statistics Data Editor 19.0 software (IBM, Somers, NY). Bivariate analysis of categoric patient variables was performed using the c 2 test, and continuous variables were analyzed using the independent samples t-test. Statistical significance was defined as P < .05. Multivariate logistic regressions were performed using backward stepwise modeling to assess the influence of certain preoperative demographic and clinical variables on the primary outcomes. All variables with a significance of < .1 on bivariate analysis were eligible for inclusion in the final model. Secondary outcomes were similarly analyzed with specific reference to postdischarge strokes and death. Institutional Human Investigations Committee exemption was obtained due to use of deidentified data.
RESULTS

Baseline demographic and clinical characteristics.
From 2005 through 2010, 33,906 CEAs were performed by vascular surgeons; among these, 30,430 (89.7%) had a patient race designation of white or black, 2611 (7.7%) were designated as unknown, 374 were designated as Hispanic (1.1%), and 364 (1.1%) were designated as Asian. The remaining patients (0.4%) were designated as American Indian or Alaska native, Native Hawaiian, or Pacific Islander. The 30,430 patients who were designated as white or black formed the basis of this analysis.
CEA was performed in 29,114 white patients (95.7%) and in 1316 black patients (4.3%) during the study period.
There were more white men (59.7%) than white women (40.3%) and more black women (54.2%) than black men (45.8%) in the study population (P < .001). Black patients were younger than white patients (68.3 6 9.7 vs 71 6 9.4 years; P < .001). There was a significantly greater prevalence of smoking, hypertension, diabetes mellitus, and dialysis dependence among black patients, although chronic obstructive pulmonary disease (COPD) was more prevalent among white patients (Table I) . No statistically significant difference was noted between the races regarding the presence of congestive heart failure in the 30 days before admission, the presence of myocardial infarction #6 months prior, or the emergent nature of the case. There was also no difference between the two racial groups in the postgraduate year level of the resident serving as the first assistant in the operating room.
Black patients were more likely to have a history of recent angina (3.8% vs 2.5%; P ¼ .005) and were more likely to be admitted from an acute or chronic care facility (4.2% vs 2.7%; P ¼ .002). White patients were more likely to have undergone prior cardiac surgery (23.2% vs 17.8%; P < .001) and were more likely to have undergone a prior percutaneous coronary intervention (19.0% vs 15.0%; P < .001).
With regard to carotid-specific symptoms, white patients were more likely to have had a prior TIA (27.9% vs 24.2%; P ¼ .003), and black patients were more likely to have had a prior stroke (24.6% vs 14.8%; P < .001). Unadjusted outcomes. Among all patients, the overall stroke and mortality rates after CEA were 1.6% and 0.7%, respectively. When stratified by race, the stroke rate was significantly higher among black patients (2.5% vs 1.6%; P ¼ .009), and the mortality rate was twice that of whites (1.4% vs 0.7%; P ¼ .002; Table II ). There was a longer operating time (130.7 6 53.8 vs 115.6 6 46.9 minutes; P < .001), greater frequency of general anesthesia (89.1% vs 84.7%; P < .001), and longer total length of inpatient hospital stay (3.6 6 5.1 vs 2.3 6 3.7 days; P < .001) among black patients. There was no difference in the rate of postoperative myocardial infarction or peripheral nerve injury between the races. Subgroup analysis revealed mortality was significantly greater for black women than white women (1.5% vs 0.8%; P ¼ .25), whereas stroke rates trended higher in black women than in white women (2.7% vs 1.7%; P ¼ .055). A similar pattern was observed in men. Black men had a significantly higher mortality than white men (1.3% vs 0.6%; P ¼ .043), but there was no significant difference in stroke between black and white men (2.3% vs 1.5%; P ¼ .109).
Timing of events. Thirty-six percent of all strokes occurred after discharge from the index hospitalization, at a mean of 8.3 6 7.4 days. Stroke occurred in 36% of whites and in 42% of blacks after discharge; this did not represent a statistically significant between-group difference. Fiftyfour percent of deaths occurred after discharge, at a mean of 11 6 8.3 days. A greater proportion of white than black patients died after discharge (56.9% vs 26.3%; P ¼ .01).
Adjusted outcomes. Logistic regression identified a history of recent angina (P < .001), prior TIA (P < .001) and stroke (with or without neurologic deficits; P < .001), transfer from another facility (P ¼ .008), and age <60 years (P ¼ .017) as independent risk factors for stroke. Final multivariate analysis found black race was a significant independent risk factor for stroke (P ¼ .049; Table III) .
Black race was identified as an independent risk factor for 30-day mortality (P ¼ .007), as were COPD (P < .001), dialysis-dependence (P < .001), history of angina (P < .001), prior stroke (P < .001), transfer from a facility (P ¼ .001), and patient age >80 years (P < .001; Table IV ). Black race was also identified as an independent risk factor for in-hospital stroke and 30-day mortality when these outcomes were combined (P ¼ .002; Table V) .
Linear regression analysis showed black race was independently associated with an increased operating time as well as an increased total hospital length of stay.
DISCUSSION
Our analysis of the ACS-NSQIP data of 30,430 white and black patients undergoing CEA demonstrated that blacks had significantly more postoperative strokes and greater 30-day mortality than white patients. Multivariate analysis identified black race as an independent risk factor for 30-day mortality, stroke, and combined stroke and death. Although there was no between-group difference in the rate of postdischarge strokes, black patients had more in-hospital deaths than white patients. Notably, 36% of strokes and 54% of deaths occurred after discharge, at a mean of 8 days and 11 days, respectively.
The overall stroke rate was 2.5% among black patients and 1.6% among white patients (P ¼ .009), which is similar to that reported by Dardik et al 10 in 2000 (3.1% and 1.6%, respectively). Among 1045 patients (133 black), Conrad et al 17 found similar perioperative stroke and death rates among black and white patients (blacks, 5.3%; whites, 3.1%; P ¼ .19). However, there was a difference between the races with regard to the long-term "all-strokes" rate (blacks, 15.8%; whites, 7.6%; P ¼ .002), defined as "any postoperative stroke, regardless of location, etiology, or interval after surgery," which was attributable to a high late stroke rate at long-term follow-up among black patients. In an 8-year review of the Medicare database, Hsia et al 18 also reported an increased rate of surgical death among blacks undergoing CEA. In our study, the higher rates of stroke and death in blacks might have been because the black patients had a higher frequency of many comorbidities and might reflect differences in access to pertinent health care. Finally, black patients had longer operating times and a higher incidence of reoperation. This could have been due to black patients having more severe forms of carotid disease or presenting at a more advanced state.
We found black race to be an independent predictor of stroke, a finding supported by Dardik et al 10 in 9842 patients over 6 years. These data diverge from the results of a recently published NSQIP analysis by Gupta et al 19 examining 13,316 patients between 2007 and 2008, of which 476 (3.6%) were black. The authors found that the postoperative incidences of stroke and death were not influenced by race. 19 Our findings may be explained by the fact that our study represents sampling of a larger population of NSQIP patients. CEA was performed in 29,114 white patients (95.7%) and in 1316 black patients (4.3%) during the study period. It is possible that our study includes a greater sample of the population of patients undergoing CEA. Because the proportion of black patients is such a minority, it would seem that in order to obtain statistical significance, a greater sample size would be required. In addition, our study was designed to ascertain factors that influenced outcomes in black vs white patients. Gupta et al 19 looked at factors affecting outcomes in all patients between 2007 and 2008. These studies differ in design, which may explain why the dependent and independent predictors of stroke and death were not identical. Despite this difference in study design, nearly all of our independent predictors of stroke or death were common to those reported by Gupta et al. 19 On bivariate analysis, with the exception of history of TIAs, bivariate analysis found all of the independent risk factors for stroke or death were seen more often among black patients. Black patients also were more likely to undergo general anesthesia for their surgery than white patients. White patients were more likely to have undergone prior cardiac surgery or a percutaneous coronary intervention. These findings may represent disparities in access to and attitudes regarding health care, as other authors have elucidated. For example, Amaranto et al 4 demonstrated that white race was an independent predictor of whether a patient would receive treatment for peripheral arterial disease and carotid artery disease.
Independent factors identified for an increased mortality were black race, a history of COPD, dialysis dependence, angina, prior stroke, admission from an acute or chronic care facility, and age >80 years. That older age was associated with mortality is noteworthy, because the mean age of the black patients was younger than that of white patients. This suggests that an interaction of multiple comorbidities contributed to the increased rate of mortality in black patients. As delineated in other studies, we found that black patients were more likely than white patients to have a history of stroke and less likely to have a history of TIAs. Oddone et al, 3 in a retrospective study involving 803 patients aged >45 years, found that 78% of black patients presented with stroke vs 55% of white patients, and 22% of black patients presented with TIA vs 45% of white patients (P ¼ .001). Such trends suggest black patients have a more significant disease burden at the time of initial presentation.
Prior studies have elucidated a number of risk factors for poor outcome after CEA. Calvillo-King et al 9 described predictors of perioperative death and stroke after CEA in 6553 asymptomatic patients. Nonwhite race was independently associated with any stroke (odds ratio, 1.83; P ¼ .023) and combined death and nonfatal stroke (odds ratio, 1.82; P ¼ .013). 9 Other predictors of perioperative events were female gender, severe disability, congestive heart failure, coronary artery disease, valvular heart disease, and a stenosis $50% that had not been operated on.
Subgroup analysis in our study found a significantly higher stroke rate in black men and women than in white men and women. Although mortality was higher in black men and women, these findings did not approach statistical significance. In ACAS, the benefits of operative intervention for asymptomatic carotid stenosis were less pronounced in women than in men, with a 5-year relative stroke risk reduction of 66% in men and 17% in women 7 ; the authors postulated that this might have been secondary to the higher perioperative complication rate among women. These findings were replicated by Goldstein et al, 20 who, in a review of 463 patients undergoing CEA for asymptomatic disease, found that women were more than three times more likely to suffer a postoperative stroke (5.3% vs 1.6%; P ¼ .01). Harthun et al, 21 examining a multicenter Virginia database of 14,095 CEAs between 1997 and 2002, found that although women had a greater rate of strokes than men (1.23% vs 0.87%; P ¼ .04), this was not independently associated with poor outcomes on multivariate analysis. This study did find, however, that nonwhite race was independently related to mortality (odds ratio, 2.33; P < .01). 21 Previous studies have reported minority women to have disproportionately elevated stroke rates after CEA. In a review of 429 patients, Rigdon et al 22 reported black women had significantly more strokes after CEA (16% vs 3%) than other patients.
We also noted that a large proportion of perioperative events (36.4% of strokes and 54.3% of deaths) occurred after discharge from the index hospitalization among all patients, at a mean of 8 and 11 days. This finding affirms the importance of standardized, prompt, outpatient follow-up among patients undergoing CEA. Because most patients go home on postoperative day 1, it seems patients are most vulnerable to these events between 1 and 2 weeks after discharge. Goodney et al, 23 using the Medicare database, reported a 30-day readmission rate of 11.2% after CEA; therefore, inpatient discharge planning that includes outpatient follow-up with a patient's primary care provider or surgeon in the days after discharge may aid in identifying and triaging developing complications and thus reducing the frequency of costly, unplanned shortterm readmissions and minimizing preventable mortality. Further studies regarding the cost-effectiveness and success of such strategies are necessary.
Our study is not without limitations. The NSQIP collects robust but fixed data regarding an array of major surgical operations and perioperative variables 13 ; for this reason, variables specific to carotid interventions, such as acute patient presentations with symptomatic stenosis, the degree of carotid stenosis, use of antiplatelet agents, and prior medical management, could not be analyzed. Because the NSQIP does not provide data regarding the time course of previous TIAs and strokes, it is possible that in a percentage of patients, these findings were remote in nature or a result of unrelated pathology. Unfortunately, specific hospital and provider characteristics are not available to authors using the NSQIP database because the information is deidentifed. Whether the much larger proportion of white patients to black patients is a discrepancy in the data set, or a reflection of a racial disparity in the delivery of care for carotid disease, could not be determined.
The potential contribution of disease distribution (intracranial vs extracranial) to outcomes in our patients remains unclear because these data are not collected by the NSQIP; further, information regarding the etiology and severity of postoperative strokes was not available for analysis. In addition, definitions of race are complex; as such, the categories provided by the NSQIP may not appropriately describe all analyzed patients. Finally, the NSQIP tracks outcome data for 30 days after surgery; thus, morbidity and mortality occurring after this time could not be assessed.
CONCLUSIONS
Black patients with carotid artery disease have significantly more comorbidities and greater morbidity and mortality after CEA than white patients. Higher stroke, death, and combined stroke-death rates in black patients undergoing CEA should be considered when considering available treatment options and should be included during the informed consent process. To our knowledge, this report represents the largest race-based analysis of patients undergoing CEA to date. A significant percentage of 30-day morbidity and mortality among CEA patients occurs after discharge; thus, strategies equipped to ensure proper follow-up and better continuity of care of patients transitioning to the outpatient setting are encouraged and should be the subject of further studies. 
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